1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A renal biopsy–anchored multi-marker signature involving AOPEP SNP-driven splicing, miR-27b-3p and glycated albumin for stratifying renal damage in type 2 diabetes
- Contribution to journal › Article
- 2022
-
Mark
Validation of the classification for type 2 diabetes into five subgroups : a report from the ORIGIN trial
Pigeyre, Marie ; Hess, Sibylle ; Gomez, Maria F. LU
; Asplund, Olof
LU
; Groop, Leif
LU
; Paré, Guillaume
and Gerstein, Hertzel
(2022)
In Diabetologia
65(1).
p.206-215
- Contribution to journal › Article
-
Mark
Phenotypic and genetic classification of diabetes
- Contribution to journal › Scientific review
- 2021
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
Leta, Valentina ; Dafsari, Haidar S. ; Sauerbier, Anna ; Metta, Vinod ; Titova, Nataliya ; Timmermann, Lars ; Ashkan, Keyoumars ; Samuel, Michael ; Pekkonen, Eero and Odin, Per LU
, et al.
(2021)
In Journal of Personalized Medicine
11(8).
- Contribution to journal › Article
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
- Contribution to journal › Article
- 2012
-
Mark
Personalised, predictive and preventive medicine: a decision-theoretic perspective
- Contribution to journal › Article